Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents ; volume:19 ; number:1 ; day:4 ; month:5 ; year:2021 ; pages:1-11 ; date:12.2021
Pediatric rheumatology ; 19, Heft 1 (4.5.2021), 1-11, 12.2021
- Urheber
-
Costagliola, Giorgio
Spada, Erika
Consolini, Rita
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12969-021-00559-5
- URN
-
urn:nbn:de:101:1-2021090720261425733072
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Costagliola, Giorgio
- Spada, Erika
- Consolini, Rita
- SpringerLink (Online service)
Ähnliche Objekte (12)
Variability in response to anti-rheumatic drugs
The Effect of Anti-rheumatic Drugs on the Skeleton
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs
Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey
ASPS Exhibits Anti‐Rheumatic Effects by Reprogramming Gut Microbiota and Increasing Serumy‐Glutamylcysteine Leve
Pediatric cardiology updates
Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue
ASPS Exhibits Anti‐Rheumatic Effects by Reprogramming Gut Microbiota and Increasing Serum γ ‐Glutamylcysteine Level
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy
The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
Variability in response to anti-rheumatic drugs
The Effect of Anti-rheumatic Drugs on the Skeleton
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs
Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey
ASPS Exhibits Anti‐Rheumatic Effects by Reprogramming Gut Microbiota and Increasing Serumy‐Glutamylcysteine Leve
Pediatric cardiology updates
Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue
ASPS Exhibits Anti‐Rheumatic Effects by Reprogramming Gut Microbiota and Increasing Serum γ ‐Glutamylcysteine Level
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy
The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
Variability in response to anti-rheumatic drugs
The Effect of Anti-rheumatic Drugs on the Skeleton
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs
Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey
ASPS Exhibits Anti‐Rheumatic Effects by Reprogramming Gut Microbiota and Increasing Serumy‐Glutamylcysteine Leve
Pediatric cardiology updates
Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue
ASPS Exhibits Anti‐Rheumatic Effects by Reprogramming Gut Microbiota and Increasing Serum γ ‐Glutamylcysteine Level
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy
The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study